Nyrada Inc Chess Depositary Interests 1:1 US Prohibited (NYR) TRADING HALT SUSPENDED

20mins delayed

Movement

1 Year Return


Nyrada Inc Chess Depositary Interests 1:1 US Prohibited Chart

Share price
Last
Change
Volume
Turnover
Market Cap $15.59 million
Today's Movement
Prev. Close
Open
Day Range -
VWAP
Historical Stats
52w Range -
4w Avg Volume
4w Avg Turnover
(delayed)
Free until 29 Feb

The BIGGEST ASX
Spreadsheet yet!

Download in Excel or PDF for printing

Data on 1,800+ ASX Companies

  • 12-month Price Targets

  • EPS & Dividends

  • 52w Highs & Lows

It's FREE until 29 February

The BIGGEST ASX Spreadsheet yet! Current Price vs 1 Yr Target Current Price from 52w High Broker Consensus Share Price Data Fundamentals Broker Consensus

NYR Statistics

21 February

1,566 / 2,267

ASX Size Rank

1yr Return

vs Sector (1yr)

-77.11%

vs ASX 200 (1yr)

-29.05%

$15.59 million

Market Cap

Share Issue

76.07 million

All Ords (%)

N/A

Short Sold

0%

Current Fundamentals

21 February

N/A

PE Ratio

EPS ($)

-

Earnings Yield

-

NTA ($)

-

N/A

Dividend Yield

DPS ($)

-

Gross Div. Yield

-

Gross DPS ($)

-

Company Overview

Nyrada Inc (NYR) is a preclinical stage, drug development company. The Company specialises in the development of novel small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. It focuses on areas of substantial unmet clinical need and has identified drug candidates with therapeutic and commercial potential, where few if any, effective or well-tolerated therapies exist. It currently has three wholly-owned drug programs:

Nyrada Inc Chess Depositary Interests 1:1 US Prohibited Logo

Corporate Details

Head Office: Wilmington Delaware
Managing Director: James Bonnar
GICS Sub-Industry: Pharmaceuticals
Date Listed: 16 Jan 2020
Registry: -
Similar Companies: MVP / MYX / SPL / EOF / AFP

Upcoming Calendar

Dividend History

Ex-Date Amount Franking Type Payable
No dividends paid in the last 5 years

See Upcoming Dividends for all ASX companies.

Announcements

Date Heading Pages File Size Time

Broker Consensus

The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.

NYR is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.

Directors & Management

About the Data


Name Title Since Bio
Mr Peter Ashley Marks Non-Executive Director Aug 2017
Dr Graham E Kelly Founder, Non-Executive Director Aug 2017
Mr John Alexander Moore Non-Executive Chairman, Non-Executive Director Jun 2019
Mr Ruediger Weseloh Non-Executive Director Jun 2019
Mr Christopher Cox Non-Executive Director Nov 2019
Mr Marcus Frampton Non-Executive Director Jun 2019
Mr David Franks Company Secretary -
Mr James Bonnar Chief Executive Officer -

Director Transactions

About the Data

NYR directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

There are no director transactions for code NYR in our database.

Shareholder Distribution

Shareholder Distribution data is unavailable.

Top 20 Shareholders

About the Data

Name Shares Capital
Noxopharm Limited 33,373,245 30.51%
Altnia Holding Pty Ltd 9,921,725 9.07%
Goodridge Nominees Pty Ltd 6,212,416 5.68%
Goodridge Nominees Pty Ltd 6,212,416 5.68%
Colin Housely & Freda Housely 1,863,725 1.70%
Sunset Capital Management Pty Ltd 1,500,000 1.37%
John W King Nominees Pty Ltd 1,242,483 1.14%
Kohen Enterprises Pty Ltd 1,070,000 0.98%
Mr Michael Francis Mcmahon & Mrs Susan Lesley Mcmahon 925,000 0.85%
RHLC Pty Limited 838,675 0.77%
Symphony Capital Holdings Llc 800,000 0.73%
Citicorp Nominees Pty Limited 750,000 0.69%
CS Third Nominees Pty Limited 750,000 0.69%
Sunshine Group Investments Pty Ltd 625,000 0.57%
Lawsam Pty Ltd 621,241 0.57%
Baywick Pty Ltd 621,241 0.57%
Phytose Corporation Pty Limited 466,551 0.43%
Albany Mechanical Services Pty Ltd 375,000 0.34%
Wolseley Road #1 Pty Limited 375,000 0.34%
AKJ Super Pty Ltd 375,000 0.34%
Xcel Capital Pty Ltd 325,000 0.30%
Boris Patkin 310,620 0.28%
Kalcon Investments Pty Ltd 300,000 0.27%
Mr Graham Arthur Robinson 300,000 0.27%
Mirage Investments Pty Ltd 300,000 0.27%
DRP 2006 Super Pty Ltd 292,425 0.27%
GT Capital Pty Ltd 265,000 0.24%
All other shareholders 35.08 %


The Top 20 Shareholders of NYR hold 64.92% of shares on issue.

NYR Share Price History

Date Close Change % Change Open High Low Volume Turnover

NYR Historical Data

Download up to 20 years of share price history.


Year Closing Price (30 June) Last Trade

Offical data as published by ASX. See more Data Downloads.

Company Details

Principal Activity: Drug research and development.

Incorporated: --

1209 Orange St
Wilmington Delaware USA 19801


All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.